We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Are Magnetic Nanoparticles Suitable for Cancer Therapy?

By Biotechdaily staff writers
Posted on 16 Jun 2008
A newly developed measuring procedure could help to investigate in some detail the behavior of magnetic nanoparticles and their potential for cancer therapy.

Researchers at the Physikalisch-Technische Bundesanstalt (PTB, Braunschweig, Germany) are researching the way magnetic nanoparticles—ranging from a few to several hundred nanometers in size--can be used as a new, promising means of fighting cancer. More...
The particles, released into the blood stream, serve as a carrier for specific drugs; they then course freely through the blood stream, until they fall under the influence of a targeting magnetic field, which holds them on to the tumor where the loaded drug releases its active agent. Besides the pharmaceutical effect, as an added bonus the electromagnetic field generates heat in the accumulated particles, destroying the tumor. Both therapeutic concepts have the advantage of largely avoiding undesired side effects on healthy tissue. In an attempt to find and investigate appropriate nanoparticles, the researchers at PTB developed magnetorelaxometry, a measurement technique in which the nanoparticles are magnetized for a brief period by a strong magnetic field in order to measure their relaxation after the switch-off of the field by means of superconducting quantum interferometers (SQUIDs).

Following magnetorelaxometry, conclusions on the nanoparticle aggregation behavior can then be drawn. Results in other fields have already served to optimize the paint drying process in the automobile industry, the thermal design of furnaces, as well as the monitoring of glass forming processes. In examining the cancer fighting potential of nanoparticles, conclusions can be drawn from measurements of their suspensions in serum or in whole blood. For example, it could be shown that certain nanoparticles in the blood serum form clusters with a diameter of up to 200 nanometers; since this a clear indication of aggregation, such nanoparticles would not appear to be suitable candidates for such therapy.

However, the high technical effort connected with the use of helium-cooled magnetic field sensors is still standing in the way of using this method routinely in practice. In a joint project with Braunschweig Technical University (Germany), the researchers at PTB are attempting to transfer the technique to a simpler technology, based on fluxgate magnetometers.


Related Links:
Physikalisch-Technische Bundesanstalt
Braunschweig Technical University

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.